These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9500129)

  • 1. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J; Saletu B; Linzmayer L; Böck G; Weissgram S; Brandstaätter N; Frey R; Saletu-Zyhlarz G
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
    Linzmayer L; Semlitsch HV; Saletu B; Böck G; Saletu-Zyhlarz G; Zoghlami A; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Grünberger J
    Arzneimittelforschung; 2001; 51(3):238-45. PubMed ID: 11304940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estazolam treatment of insomnia in generalized anxiety disorder: a placebo-controlled study.
    Post GL; Patrick RO; Crowder JE; Houston J; Ferguson JM; Bielski RJ; Bailey L; Pearlman HG; Shu VS; Pierce MW
    J Clin Psychopharmacol; 1991 Aug; 11(4):249-53. PubMed ID: 1918423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S; Lader M
    Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia.
    Agnoli A; Manna V; Martucci N
    Int J Clin Pharmacol Res; 1989; 9(4):277-81. PubMed ID: 2674029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
    Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lorazepam on fear-potentiated startle responses in man.
    Graham SJ; Scaife JC; Langley RW; Bradshaw CM; Szabadi E; Xi L; Crumley T; Calder N; Gottesdiener K; Wagner JA
    J Psychopharmacol; 2005 May; 19(3):249-58. PubMed ID: 15888510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of lormetazepam and flurazepam in the treatment of insomnia.
    Melo de Paula AJ
    Clin Ther; 1984; 6(4):500-8. PubMed ID: 6380724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial.
    Glass JR; Sproule BA; Herrmann N; Busto UE
    J Clin Psychopharmacol; 2008 Apr; 28(2):182-8. PubMed ID: 18344728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical-experimental testing of the effects of a new hypnotic on respiratory function in healthy subjects and in patients with chronic-obstructive syndrome].
    Mühlberger F
    Schweiz Rundsch Med Prax; 1992 Jun; 81(25):838-40. PubMed ID: 1439406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.